PARDES BIOSCIENCES, INC. 3 SEC Filings

Filed On	Filing
16 Sep 2022	Form 3: Pottage John C Jr, Director No securities owned
16 Sep 2022	Form 3: Smaldone Alsup Laurie, Director No securities owned
04 Mar 2022	Form 3: Wiggans Thomas G, Director No securities owned
27 Dec 2021	Form 3: Hamill Laura, Director
27 Dec 2021	Form 3: Lobell J Jay, Director Holds 3,591,265 shares of Common Stock
27 Dec 2021	Form 3: Henson Heidi, Chief Financial Officer Holds 316,753 shares of Common Stock
27 Dec 2021	Form 3: Lacy Elizabeth H., General Counsel & Corp. Secy Holds 211,169 shares of Common Stock
27 Dec 2021	Form 3: Lopatin Uri A, Director Holds 5,327,798 shares of Common Stock
27 Dec 2021	Form 3: Auerbach Mark, Director Holds 70,390 shares of Common Stock
27 Dec 2021	Form 3: Arnold Lee D, Chief Scientific Officer Holds 2,815,585 shares of Common Stock
27 Dec 2021	Form 3: Varney Michael David, Director Holds 70,390 shares of Common Stock
27 Dec 2021	Form 3: Brusky Sean P., Chief Commercial Officer
27 Dec 2021	Form 3: Tinmouth Brian Philippe, Chief Business & Strategy Ofcr
27 Dec 2021	Form 3: Autor Deborah M., Director
27 Dec 2021	Form 3: Kearney Brian, Chief Development Officer Holds 457,533 shares of Common Stock
25 Mar 2021	Form 3: Foresite Capital Opportunity Fund V, L.p., 10% owner and 1 other Holds 602,500 shares of Class A Common Stock
16 Feb 2021	Form 3: Hughes Owen, Director
16 Feb 2021	Form 3: Rome Michael E, Director No securities owned
16 Feb 2021	Form 3: Tananbaum James B., Director
16 Feb 2021	Form 3: Pakianathan Deepika, Director

Comments